Europe Viral Inactivation Market is estimated to be growing at a CAGR of 12.1%, to reach USD 170 million by 2021
Europe Viral Inactivation Market By Method, By Product, By Application And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (20162021)
(EMAILWIRE.COM, October 11, 2017 ) The Europe Viral Inactivation Market was worth USD 95 million in 2016 and estimated to be growing at a CAGR of 12.1%, to reach USD 170 million by 2021. Viral Inactivation is the method by which viral cells are killed or made inactive. It is done in order to enhance the safety and to prevent contamination of products by viruses. If the viruses are present in the final product, they are in inactive form. All the inactivation techniques are done primarily in blood plasma and food industries to protect the products from viruses.
View full report @ http://www.marketdataforecast.com/market-reports/europe-viral-inactivation-market-3231/
Among the many methods in which Viral Inactivation is done, some of them are , irradiation by UV rays, dry heating, pasteurization, solvent/detergent usage and lowering the pH among others. Pasteurization is useful only if the proteins to be protected have more thermal resistance than the viruses to be killed. UV radiations achieves the ends by creating nucleic acid dimers, thus affecting life cycle and reproduction processes of viruses. Viral Inactivation by solvents and detergents is the most commonly used method in the blood plasma industry, but it is effective only for viruses encapsulated in lipid molecules. The detergents/solvents interacts with the lipid layers in which viruses are present and make them ineffective since they cannot survive without lipid molecules. Lowering pH is effective when the molecules in the product are more resistant than viruses.
The driving factors of Europe Viral Inactivation market are focus of research and development industries in life sciences, high growth in pharmaceuticals and biotechnology industries, launch of new drugs, rising incidence of chronic diseases and growing support of government in biotechnology and pharmaceuticals sectors among others. However, this market is constrained by presence of strong consolidation and less number of skilled workers.
Request sample @ http://www.marketdataforecast.com/market-reports/europe-viral-inactivation-market-3231/request-sample
The Europe Viral Inactivation market is segmented on the basis of method, product, application and end-user. Based on method, the market is segmented into solvent/detergent method, pasteurization, UV radiation, microwave heating and high-energy light. The largest market share is held by solvent/detergent method since it requires less investment, easy to use and it achieves high degree of inactivation of viruses. Based on product the market is divided into services, kits and reagents, accessories and viral inactivation systems. With respect to application, the market is fragmented into vaccines and therapeutics, stem cell products, cell culture, gene therapy and blood & blood products. Vaccines and therapeutics has the largest share in this segment. Based on end-users, the market is segmented into academic institutions, research organisations, pharmaceutical companies and others.
The Europe market for Viral Inactivation is geographically segmented into United Kingdom, Spain, France, Italy and Germany. Europe is the second largest market in the world by share. Factors such as rising support of government in pharmaceuticals and biotechnology sectors and rising incidence of chronic diseases is expected to drive the growth of this market in the forecast period.
Some of the major players in the market include Clean Cells, Charles River Laboratories International Inc, Danaher Corporation, Merck KGaA, Parker Hannifin, Red Source Technologies, Sartorius AG, SGS S.A, Texcell Inc, Viral Inactivated Plasma Systems SA, and WuXi Pharma Tech Inc.
Market Segmentation
1) Method
Solvent/Detergent Method
Pasteurization
UV Radiation
Microwave Heating
High-Energy Light
Y-o-Y Growth Analysis, By Method
Market Attractiveness Analysis, By Method
Market Share Analysis, By Method
2) Product
Kits and Reagents
Services
Accesories
Viral Inactivation Systems
Y-o-Y Growth Analysis, By Product
Market Attractiveness Analysis, By Product
Market Share Analysis, By Product
3) Application
Vaccines and Therapeutics
Stem Cell Products
Cell Culture
Gene Therapy
Blood & Blood Products
Y-o-Y Growth Analysis, By Application
Market Attractiveness Analysis, By Application
Market Share Analysis, By Application
4) End User
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Academic Research Institutes
Other End Users
Y-o-Y Growth Analysis, By End User
Market Attractiveness Analysis, By End User
Market Share Analysis, By End User
Inquire before buying@ http://www.marketdataforecast.com/market-reports/europe-viral-inactivation-market-3231/inquire
Scope of the project :
Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analysing the level of competition and business strategy development
A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
View full report @ http://www.marketdataforecast.com/market-reports/europe-viral-inactivation-market-3231/
Among the many methods in which Viral Inactivation is done, some of them are , irradiation by UV rays, dry heating, pasteurization, solvent/detergent usage and lowering the pH among others. Pasteurization is useful only if the proteins to be protected have more thermal resistance than the viruses to be killed. UV radiations achieves the ends by creating nucleic acid dimers, thus affecting life cycle and reproduction processes of viruses. Viral Inactivation by solvents and detergents is the most commonly used method in the blood plasma industry, but it is effective only for viruses encapsulated in lipid molecules. The detergents/solvents interacts with the lipid layers in which viruses are present and make them ineffective since they cannot survive without lipid molecules. Lowering pH is effective when the molecules in the product are more resistant than viruses.
The driving factors of Europe Viral Inactivation market are focus of research and development industries in life sciences, high growth in pharmaceuticals and biotechnology industries, launch of new drugs, rising incidence of chronic diseases and growing support of government in biotechnology and pharmaceuticals sectors among others. However, this market is constrained by presence of strong consolidation and less number of skilled workers.
Request sample @ http://www.marketdataforecast.com/market-reports/europe-viral-inactivation-market-3231/request-sample
The Europe Viral Inactivation market is segmented on the basis of method, product, application and end-user. Based on method, the market is segmented into solvent/detergent method, pasteurization, UV radiation, microwave heating and high-energy light. The largest market share is held by solvent/detergent method since it requires less investment, easy to use and it achieves high degree of inactivation of viruses. Based on product the market is divided into services, kits and reagents, accessories and viral inactivation systems. With respect to application, the market is fragmented into vaccines and therapeutics, stem cell products, cell culture, gene therapy and blood & blood products. Vaccines and therapeutics has the largest share in this segment. Based on end-users, the market is segmented into academic institutions, research organisations, pharmaceutical companies and others.
The Europe market for Viral Inactivation is geographically segmented into United Kingdom, Spain, France, Italy and Germany. Europe is the second largest market in the world by share. Factors such as rising support of government in pharmaceuticals and biotechnology sectors and rising incidence of chronic diseases is expected to drive the growth of this market in the forecast period.
Some of the major players in the market include Clean Cells, Charles River Laboratories International Inc, Danaher Corporation, Merck KGaA, Parker Hannifin, Red Source Technologies, Sartorius AG, SGS S.A, Texcell Inc, Viral Inactivated Plasma Systems SA, and WuXi Pharma Tech Inc.
Market Segmentation
1) Method
Solvent/Detergent Method
Pasteurization
UV Radiation
Microwave Heating
High-Energy Light
Y-o-Y Growth Analysis, By Method
Market Attractiveness Analysis, By Method
Market Share Analysis, By Method
2) Product
Kits and Reagents
Services
Accesories
Viral Inactivation Systems
Y-o-Y Growth Analysis, By Product
Market Attractiveness Analysis, By Product
Market Share Analysis, By Product
3) Application
Vaccines and Therapeutics
Stem Cell Products
Cell Culture
Gene Therapy
Blood & Blood Products
Y-o-Y Growth Analysis, By Application
Market Attractiveness Analysis, By Application
Market Share Analysis, By Application
4) End User
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Academic Research Institutes
Other End Users
Y-o-Y Growth Analysis, By End User
Market Attractiveness Analysis, By End User
Market Share Analysis, By End User
Inquire before buying@ http://www.marketdataforecast.com/market-reports/europe-viral-inactivation-market-3231/inquire
Scope of the project :
Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analysing the level of competition and business strategy development
A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Contact Information:
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results